Concetta Press
Independent Open-Access Scientific Publishing
Independent Open-Access Scientific Publishing
Concetta Press is guided by an international editorial leadership committed to fair, rapid, and sound scientific publishing.
Executive Editor
Award-winning Australian artificial intelligence researcher, author, educator, entrepreneur, and technology leader; CEO and Director of Cogninet Australia since 2012; Academic Dean since 2022.
Editor-in-Chief
Senior Research Scientist, Department of Medicine
Columbia University, New York, Honorary Principal Research Fellow, Imperial College London
Research interests include heart arrhythmia analysis and onset and the amelioration of celiac disease.
✉ ejc6@cumc.columbia.edu
𝕏 @EdwardCiaccio
🌐Webpage 🌐Ignatius Journal Services
⬇️ Download CV
Executive Editor
Mr. Senlin Yan is Manager, Hongkong Bosen Academic Research Institute Co., Limited (since 2010). He is also affiliated with China University of Geosciences (Bachelors' degree, 2008). Part of his work involves organizing and coordinating academic meetings and conferences worldwide, to enhance the exchange of information and to foster collaborative efforts between scientists.
Advisor
President and CEO of inHEART Medical. He brings over 20 years of experience woring with complex enterprises and startup organizations across continents and various industries. Before inHEART, Todor Jeliaskov was CEO of NuVera Medical, acquired by Biosense Webster (Johnson & Johnson) in November 2020. NuVera developed the next-generation intracardiac imaging technology for cardiac interventions - 4D ICE. He previously served as VP at GE Ultrasound - the worldwide market leader in diagnostic ultrasound. Todor Jeliaskov started his career at Siemens Medical Solutions. He holds a Ph.D. in Electrical Engineering and an MBA degree.
✉ contact@inheartmedical.com
𝕏 @TJeliaskov
🌐Webpage 🌐inHEART
Advisor
Mr. David Robinson is a Senior Consultant for US Market Development at inHEART, a medical device company specializing in AI-driven 3D cardiac modeling, since 2015. He is an expert in electrophysiology and medical devices, cardiac mapping, and ablation of complex arrhythmias in progressive disease states. He is also experienced in the commercialization of new technology, product launch strategies, and market development. His previous background includes roles at Voyage Medical, Inc., Boston Scientific, and Cardiac Pathways Corp. inHEART Medical develops AI-enabled digital twin models of the heart to improve ablation therapy for cardiac arrhythmias.
✉ contact@inheartmedical.com
𝕏 @inheartmedical
🌐Webpage 🌐inHEART